Hypercatabolic syndrome: Molecular basis and effects of nutritional supplements with amino acids

被引:63
|
作者
Pasini, Evasio [1 ]
Aquilani, Roberto [2 ]
Dioguardi, Francesco S. [3 ]
D'Antona, Giuseppe [4 ]
Gheorghiade, Mihai [5 ]
Taegtmeyer, Heinrich [6 ]
机构
[1] Fdn Salvatore Maugeri, IRCCS, Med Ctr Lumezzane, Sci Inst Lumezzane, I-25066 Brescia, Italy
[2] Fdn Salvatore Maugeri, IRCCS, Serv Metab & Nutr Pathophysiol, Med Ctr Montescano, Pavia, Italy
[3] Univ Milan, Dept Internal Med, Milan, Italy
[4] Univ Pavia, Dept Expt Med, Human Physiol Unit, I-27100 Pavia, Italy
[5] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Univ Texas Houston, Sch Med, Dept Internal Med, Div Cardiol, Houston, TX USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2008年 / 101卷 / 11A期
关键词
D O I
10.1016/j.amjcard.2008.02.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercatabolic syndrome (HS) is a biochemical state characterized by increased circulating catabolic hormones (eg, cortisol, catecholamines) and inflammatory cytokines (eg, tumor necrosis factors, interleukin-10), and decreased anabolic insulin effects with consequent insulin resistance. The most important metabolic consequence of HS is the skeletal and cardiac muscle protein breakdown that releases amino acids (AAs), which in turn supports indispensable body energy requirements but also reduces skeletal and cardiac physiologic and metabolic functions. HS occurs in many diseases such as diabetes mellitus, chronic heart failure, chronic obstructive pulmonary disease, renal and liver failure, trauma, sepsis, and senescence. All of these conditions have predominant catabolic molecules with significant muscular wasting and metabolic impairment. Macronutrients such as AA supplements, taken together with conventional therapy, may maintain muscular protein metabolism and cell functions. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:11E / 15E
页数:5
相关论文
共 50 条